284 related articles for article (PubMed ID: 14604829)
1. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene.
Yamada R; Suzuki A; Chang X; Yamamoto K
Trends Mol Med; 2003 Nov; 9(11):503-8. PubMed ID: 14604829
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
3. Citrullination by peptidylarginine deiminase in rheumatoid arthritis.
Suzuki A; Yamada R; Yamamoto K
Ann N Y Acad Sci; 2007 Jun; 1108():323-39. PubMed ID: 17893996
[TBL] [Abstract][Full Text] [Related]
4. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis.
Yamada R
Autoimmun Rev; 2005 Apr; 4(4):201-6. PubMed ID: 15893712
[TBL] [Abstract][Full Text] [Related]
6. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.
Suzuki A; Yamada R; Chang X; Tokuhiro S; Sawada T; Suzuki M; Nagasaki M; Nakayama-Hamada M; Kawaida R; Ono M; Ohtsuki M; Furukawa H; Yoshino S; Yukioka M; Tohma S; Matsubara T; Wakitani S; Teshima R; Nishioka Y; Sekine A; Iida A; Takahashi A; Tsunoda T; Nakamura Y; Yamamoto K
Nat Genet; 2003 Aug; 34(4):395-402. PubMed ID: 12833157
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility genes in rheumatoid arthritis: peptidylarginine deiminase (PADI) type 4].
Yamada R
Nihon Rinsho; 2005 Jan; 63 Suppl 1():127-30. PubMed ID: 15799331
[No Abstract] [Full Text] [Related]
8. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
9. Genetic background of tolerance breakdown in rheumatoid arthritis.
Kochi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(2):48-56. PubMed ID: 20453439
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
12. The immune response to citrullinated antigens in autoimmune diseases.
Migliorini P; Pratesi F; Tommasi C; Anzilotti C
Autoimmun Rev; 2005 Nov; 4(8):561-4. PubMed ID: 16214096
[TBL] [Abstract][Full Text] [Related]
13. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
Cheng J; Zhang H; Zhuang C; Liu R
J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
[TBL] [Abstract][Full Text] [Related]
15. PADI2 is significantly associated with rheumatoid arthritis.
Chang X; Xia Y; Pan J; Meng Q; Zhao Y; Yan X
PLoS One; 2013; 8(12):e81259. PubMed ID: 24339914
[TBL] [Abstract][Full Text] [Related]
16. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
[TBL] [Abstract][Full Text] [Related]
17. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.
Harris ML; Darrah E; Lam GK; Bartlett SJ; Giles JT; Grant AV; Gao P; Scott WW; El-Gabalawy H; Casciola-Rosen L; Barnes KC; Bathon JM; Rosen A
Arthritis Rheum; 2008 Jul; 58(7):1958-67. PubMed ID: 18576335
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
[TBL] [Abstract][Full Text] [Related]
20. Association of PADI4 and rheumatoid arthritis: a successful multidisciplinary approach.
Worthington J; John S
Trends Mol Med; 2003 Oct; 9(10):405-7. PubMed ID: 14557050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
